11-77336090-A-C
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_002576.5(PAK1):c.1409T>G(p.Leu470Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L470Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_002576.5 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual developmental disorder with macrocephaly, seizures, and speech delayInheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAK1 | NM_002576.5 | c.1409T>G | p.Leu470Arg | missense_variant | Exon 13 of 15 | ENST00000356341.8 | NP_002567.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Intellectual developmental disorder with macrocephaly, seizures, and speech delay Pathogenic:2
Criteria applied: PS2_MOD,PM1,PM5,PS4_SUP,PM2_SUP,PP3; Re-Eval 23.11.2023 RoJ -
This PAK1 variant is absent from a large population dataset and has not been reported in the literature, to our knowledge. It has an entry in ClinVar. Three bioinformatics tools queried predict that this substitution would be damaging, and the leucine residue at this position is conserved across all vertebrate species assessed. This leucine to arginine substitution is located in PAK1 kinase domain. The crystal structure of the human PAK1 protein shows this residue (Leu470) interacts with the inhibitory switch (IS) domain, which is required for autoinhibition of PAK1 kinase activity. This variant is not predicted to affect normal exon 13 splicing, although this has not been confirmed experimentally to our knowledge. We consider c.1409T>G to be likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at